Press releases

"This strong start enables us to raise our outlook for the year,” said Boston Scientific CEO Mike Mahoney

FDA approval includes ACCOLADE™ MRI and ESSENTIO™ MRI pacemakers and INGEVITY™ MRI pacing leads

Boston Scientific will participate in the healthcare investor conference on May 5, 2016. A live webcast and replay will be available.

European approval granted for third-generation system and all previously implanted, second-generation systems

No reports of patient injury or death; no risk to patients who previously underwent a thrombectomy with the Fetch 2 catheter

The company rejects the allegations in the petition to the Food and Drug Administration filed by a Texas-based law firm

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2016. Learn how to tune in.

Boston Scientific will participate in the healthcare conference on April 12, 2016. A live webcast and replay will be available.

Scheduled abstracts will highlight 'real-world' and clinical trial experiences with technologies developed to treat patients with a range of cardiovascular diseases

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the AXIOS™ Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complications from...

Two organizations to share intellectual property and stimulate the rapid development of medical devices to address unmet clinical needs

FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter

Boston Scientific will participate in the healthcare conference on March 15, 2016. Learn how to watch the webcast or replay.

Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman

Boston Scientific will participate in the healthcare conference on March 8, 2016. Learn how to watch the webcast or replay.

ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in trial pursuing MRI labeling for cardiac defibrillation and resynchronization systems

First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe

CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met

"Our accomplishments in 2015 demonstrate our continued momentum,” said Boston Scientific CEO Mike Mahoney

Bronchial thermoplasty (BT) delivered by the ALAIR™ System offers proven reduction in asthma attacks for adults with severe asthma not well controlled with medication

Care Pathway Transformation solution is designed to enable providers to make better-informed decisions based on patient population insights

Boston Scientific will participate in the healthcare conference on February 10, 2016. Learn how to watch the webcast or replay.

Single-use system for stone removal eliminates maintenance, reprocessing and sterilization

Boston Scientific will webcast its conference call discussing financial results and business highlights for Q4 ended December 31, 2015

Boston Scientific will participate in the healthcare investor conference on January 12, 2016. Learn how to watch the webcast or replay.

Study demonstrates spinal cord stimulation device provided significant decrease in average pain scores sustained over a two-year period

Recall affects all UPNs of the Chariot Guiding Sheaths; to date, no permanent injuries or patient deaths have been reported

Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe

Boston Scientific will participate in the healthcare conference on December 8, 2015. Learn how to watch the webcast or replay.

First implants occur in Europe, commencing limited market release

For the second consecutive year, Boston Scientific is named one of the "Best Places to Work for LGBT Equality"

Boston Scientific will participate in the healthcare conference on December 1, 2015. Learn how to watch the webcast or replay.

Transaction to expand interventional oncology portfolio with drug-eluting microspheres and spherical embolics

Boston Scientific will participate in an upcoming medtech and diagnostics conference on Nov. 19, 2015. A live webcast and replay will be available.

Boston Scientific will participate in the healthcare conference on November 17, 2015. Learn how to watch the webcast or replay.

"Our excellent third quarter performance was driven by strong sales and differentiated adjusted operating margin expansion," said CEO Mike Mahoney

Investment continues alliance for percutaneous mitral valve replacement established in 2012

Up to $25,000 in prizes to be awarded to winners

Clinical and economic data to be presented at world's leading interventional cardiology meeting

New category of drug-eluting stent approved for U.S. patients

Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ended Oct. 28, 2015. Learn how to tune in.

Provides minimally invasive alternative to an esophagectomy

MAJESTIC trial data support strong safety profile with low target lesion revascularization rate

System includes first directional lead with current steering and expanded programming flexibility

Boston Scientific will participate in the Morgan Stanley healthcare conference on Sept. 17, 2015. Learn how to watch the webcast or replay.

Boston Scientific will participate in the healthcare conference on Sept. 9, 2015. Learn how to watch the webcast or replay.

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems

U.S. launch underway for therapy designed to treat Peripheral Artery Disease

Men’s health and prostate health acquisition positions Boston Scientific as a urology leader

Strategic alliance to expand Boston Scientific portfolio of remote monitoring solutions

"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.

First guidewire designed specifically for TAVI/R now sized for smaller ventricles

First Patients Enrolled in the FAST Feasibility Study

Chairman Pete Nicholas welcomes James as a business leader with “significant financial knowledge, HR management and organizational planning skills.”

Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma

Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ending June 15, 2015. Learn how to tune in.

Study to evaluate patients implanted with S-ICD for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function

Spinal cord stimulator (SCS) system provided 1.5x better overall pain relief and 2x better low back pain relief than previous generation system

World's smallest 16-contact high-capacity primary cell device expands spinal cord stimulator system (SCS) offering

Boston Scientific will participate in the healthcare conference on June 9, 2015. Learn how to watch the webcast or replay.

Compelling results presented at EuroPCR 2015 add to growing body of evidence supporting performance and safety

Additional data from EVOLVE II pivotal trial demonstrate safety and performance in patients with diabetes at one year

Boston Scientific Corporation (NYSE: BSX) announced its completed public offering of senior notes

Key data from 42 abstracts to include presentations on the WATCHMAN device and the EMBLEM S-ICD system.

Boston Scientific Corporation (NYSE: BSX) announced its pricing of a public offering of senior notes

Recognition from Shingo Institute is the second in two years for a company facility

CEO Mike Mahoney will outline company's unique opportunities to bring forward meaningful innovation

Customized programs to drive operational and care pathway improvements

"We achieved strong results in the first quarter and continue to build global momentum," said CEO Mike Mahoney

MAJESTIC trial meets performance endpoint with compelling results

Boston Scientific will participate in an upcoming healthcare conference on May 12, 2015. A live webcast and replay will be available.

Collaboration provides patients and physicians a comprehensive portfolio for Deep Brain Stimulation (DBS) therapy

Boston Scientific will participate in an upcoming healthcare conference on May 6, 2015. A live webcast and replay will be available.

Results published in the Journal of American College of Cardiology

Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation System, initiating a study with a novel design to isolate the...

Companies plan to accelerate physician training and expand utilization of less-invasive endoscopy technologies in China

Acquisition will bring minimally invasive devices for Endoscopic Ultrasound (EUS) into company portfolio

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 on April 28, 2015. Learn how to tune in.

Novel stroke risk reduction option for indicated patients with atrial fibrillation

Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest

First-of-its-kind alternative to long-term warfarin therapy for stroke risk reduction in patients with non-valvular atrial fibrillation

Chairman Pete Nicholas welcomed the two new board members: "Their extensive experience and management insights will be valuable additions."

Combined business to advance patient care with leading solutions across major urology categories

Boston Scientific will participate in an upcoming healthcare conference on March 10, 2015. A live webcast and replay will be available.

New-generation system is designed to optimize procedural efficiency and productivity

Boston Scientific will participate in an upcoming healthcare conference on March 4, 2015. A live webcast and replay will be available.

Action against Guidant stemmed from Boston Scientific's acquisition

Boston Scientific will participate in the upcoming healthcare conference on Feb. 25, 2015. A live webcast and replay will be available. Read more.

Boston Scientific will participate in the upcoming healthcare conference on Feb. 11, 2015. A live webcast and replay will be available. Read more.

Agreement provides physicians with a comprehensive solution to prepare and treat diseased femoropopliteal vessels

"2014 was another year of significant achievement for Boston Scientific," said Mike Mahoney, chairman and CEO

IndustryWeek recognition highlights manufacturing excellence

Implantable cardioverter defibrillators projected to last nearly 12 years, double the battery capacity of other ICDs

Competition to showcase innovative ideas and encourage entrepreneurialism among early-stage medical device companies

Boston Scientific will host and webcast an Investor Day business review meeting on May 1, 2015. Learn how to tune in or watch the replay.

Boston Scientific will webcast its conference call with financial results and business highlights for Q4 and FY ended Dec. 31, 2014. Learn how to tune in.

Boston Scientific will participate in the upcoming healthcare conference on Jan. 13, 2015. A live webcast and replay will be available. Read more.

Boston Scientific will participate in the upcoming healthcare conference on Jan. 6, 2015. A live webcast and replay will be available. Read more.

Significant relief achieved using Advanced Illumina™ 3D programming software

Highest rating of 100 percent distinguishes company as one of the "Best Places to Work for LGBT Equality"